HB-EGF: A Novel Therapeutic Target to Modulate Repair in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Immunology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology
Nat. Immunol. 2024 Mar 01;25(3)432-447, M Linnerbauer, L Lößlein, O Vandrey, A Peter, Y Han, T Tsaktanis, E Wogram, M Needhamsen, L Kular, L Nagel, J Zissler, M Andert, L Meszaros, J Hanspach, F Zuber, UJ Naumann, M Diebold, MA Wheeler, T Beyer, L Nirschl, A Cirac, FB Laun, C Günther, J Winkler, T Bäuerle, M Jagodic, B Hemmer, M Prinz, FJ Quintana, V RothhammerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.